Victory Capital Management Inc. Purchases 53,619 Shares of ICU Medical, Inc. $ICUI

Victory Capital Management Inc. increased its position in ICU Medical, Inc. (NASDAQ:ICUI) by 33.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 212,520 shares of the medical instruments supplier’s stock after purchasing an additional 53,619 shares during the quarter. Victory Capital Management Inc. owned approximately 0.86% of ICU Medical worth $25,494,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. SJS Investment Consulting Inc. lifted its holdings in shares of ICU Medical by 41,000.0% during the 3rd quarter. SJS Investment Consulting Inc. now owns 411 shares of the medical instruments supplier’s stock worth $49,000 after acquiring an additional 410 shares during the period. Covestor Ltd increased its stake in ICU Medical by 70.7% in the third quarter. Covestor Ltd now owns 570 shares of the medical instruments supplier’s stock valued at $68,000 after acquiring an additional 236 shares during the period. Smartleaf Asset Management LLC increased its stake in ICU Medical by 11.6% in the second quarter. Smartleaf Asset Management LLC now owns 969 shares of the medical instruments supplier’s stock valued at $128,000 after acquiring an additional 101 shares during the period. Headlands Technologies LLC acquired a new position in ICU Medical in the second quarter worth about $177,000. Finally, United Services Automobile Association bought a new position in ICU Medical during the first quarter worth about $218,000. Institutional investors own 96.10% of the company’s stock.

ICU Medical Price Performance

NASDAQ:ICUI opened at $133.34 on Tuesday. The company has a quick ratio of 1.15, a current ratio of 2.39 and a debt-to-equity ratio of 0.60. The firm has a market cap of $3.29 billion, a PE ratio of 6,670.34, a price-to-earnings-growth ratio of 1.90 and a beta of 0.79. ICU Medical, Inc. has a 12 month low of $107.00 and a 12 month high of $160.29. The company’s 50-day moving average price is $148.93 and its two-hundred day moving average price is $138.06.

ICU Medical (NASDAQ:ICUI) last posted its earnings results on Thursday, February 19th. The medical instruments supplier reported $1.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.68 by $0.23. The company had revenue of $535.94 million during the quarter, compared to analysts’ expectations of $541.20 million. ICU Medical had a net margin of 0.03% and a return on equity of 7.33%. ICU Medical’s quarterly revenue was down 14.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.11 earnings per share. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. On average, equities analysts anticipate that ICU Medical, Inc. will post 4.11 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ICUI has been the topic of a number of recent research reports. Wall Street Zen raised ICU Medical from a “hold” rating to a “buy” rating in a report on Sunday, February 15th. Weiss Ratings restated a “sell (d-)” rating on shares of ICU Medical in a research report on Thursday, January 22nd. KeyCorp boosted their price target on ICU Medical from $175.00 to $180.00 and gave the company an “overweight” rating in a research note on Friday, February 20th. Finally, Piper Sandler upped their price target on ICU Medical from $172.00 to $178.00 and gave the company an “overweight” rating in a research report on Friday, February 20th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $179.33.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.